Skip to main content

Generics

  • J&J’s Actelion acquisition expected to close this quarter

    NEW BRUNSWICK, N.J. — Johnson & Johnson confirmed Tuesday during its 2017 fiscal first-quarter earnings report that it expects its $30 billion acquisition of Actelion to close this quarter.

    “The public tender offer for Actelion has been declared successful based on the number of shares tendered and regulatory approval has been obtained in six of seven jurisdictions in which the company filed for such approval, with antitrust approval from the European Commission pending.”

  • NYT: Amid investigations, Lannett continues to raise prices

  • Indian government approves Baxter acquisition of Claris

    AHMEDABAD, India — India’s Foreign Investment Promotion Board on Monday approved Baxter Healthcare’s acquisition of India-based Claris Injectables for $625 million, according to multiple news reports. The Foreign Investment Promotion Board has the ability to approve mergers and transactions, similar to the Federal Trade Commission in the United States.

    Baxter anticipates launching seven to nine new products annually over the next few years, increasing to 10 to 15 anticipated new product launches a year beyond 2019.

  • Missouri final state to pass prescription drug pricing database legislation

    JEFFERSON CITY, Mo. — Missouri’s State Senate passed legislation to make it the final state to adopt a prescription drug pricing database. The bill would create a database pharmacists and doctors could check to see if patients have recently filled or been prescribed addictive medications.

  • Amneal Pharmaceuticals launches its first product in spray form

    BRIDGEWATER, N.J. — Amneal Pharmaceuticals launched mometasone furoate nasal spray, the company's first pharmaceutical product in spray form. 

    Mometasone furoate, available in 50 mcg/spray strength, is an AB-rated therapeutic equivalent to Nasonex. Amneal's generic comes packaged in a white, high-density, polyethylene bottle fitted with a white, metered-dose, manual spray pump and turquoise cap. Each 17-gram bottle delivers 120 sprays.

  • Prozac generic earns FDA approval

    GUJARAT, India — Alembic Pharmaceuticals announced it received Food and Drug Administration approval for generic Fluoxetine Hydrochloride tablets, 10mg and 20mg, used for the treatment of depression and panic disorder. 

    This pharmaceutical is a generic version of Eli Lilly's Prozac tablets.

    Common side effects associated with the drug include headache, dizziness, diarrhea and weakness.

  • Akorn confirms discussions to be potentially acquired

    LAKE FOREST, Ill. — Specialty generic pharmaceutical company Akorn confirmed it is in talks to be possibly be acquired by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA.

  • Reports: Teva weighing sale of women’s health unit

    JERUSALEM — Teva Pharmaceuticals is considering a sale of its women’s health unit, which could earn the company $2 billion in proceeds, according to multiple news reports.

    Teva is reportedly working with Morgan Stanley to find a buyer and could begin the process as early as May, reported Israeli newspaper Globes.

    Teva acquired the women’s health division from Merck KGaA’s Merck Serono in 2010.

X
This ad will auto-close in 10 seconds